Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Ardent Health Inc (NYSE: ARDT) closed at $8.69 down -1.70% from its previous closing price of $8.84. In other words, the price has decreased by -$1.70 from its previous closing price. On the day, 0.31 million shares were traded. ARDT stock price reached its highest trading level at $8.835 during the session, while it also had its lowest trading level at $8.53.
Ratios:
For a deeper understanding of Ardent Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.95 and its Current Ratio is at 2.08. In the meantime, Its Debt-to-Equity ratio is 1.84 whereas as Long-Term Debt/Eq ratio is at 1.82.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $19.Goldman initiated its Neutral rating on October 14, 2025, with a $19 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDT now has a Market Capitalization of 1244300928 and an Enterprise Value of 3307650048. As of this moment, Ardent’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.02, and their Forward P/E ratio for the next fiscal year is 6.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20 while its Price-to-Book (P/B) ratio in mrq is 1.00. Its current Enterprise Value per Revenue stands at 0.523 whereas that against EBITDA is 6.23.
Stock Price History:
The Beta on a monthly basis for ARDT is 0.72, which has changed by -0.3594203 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, ARDT has reached a high of $15.98, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is -10.77%, while the 200-Day Moving Average is calculated to be -29.61%.
Shares Statistics:
For the past three months, ARDT has traded an average of 550.49K shares per day and 357630 over the past ten days. A total of 143.17M shares are outstanding, with a floating share count of 23.22M. Insiders hold about 83.78% of the company’s shares, while institutions hold 14.12% stake in the company. Shares short for ARDT as of 1767139200 were 2682687 with a Short Ratio of 4.87, compared to 1764288000 on 2718255. Therefore, it implies a Short% of Shares Outstanding of 2682687 and a Short% of Float of 8.0299996.
Earnings Estimates
. The current assessment of Ardent Health Inc (ARDT) involves the perspectives of 4.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.22, with high estimates of $0.28 and low estimates of $0.18.
Analysts are recommending an EPS of between $1.86 and $1.86 for the fiscal current year, implying an average EPS of $1.86. EPS for the following year is $1.42, with 5.0 analysts recommending between $1.6 and $1.18.
Revenue Estimates
A total of 11 analysts believe the company’s revenue will be $1.63B this quarter.It ranges from a high estimate of $1.68B to a low estimate of $1.6B. As of. The current estimate, Ardent Health Inc’s year-ago sales were $1.61BFor the next quarter, 11 analysts are estimating revenue of $1.59B. There is a high estimate of $1.64B for the next quarter, whereas the lowest estimate is $1.56B.
A total of 12 analysts have provided revenue estimates for ARDT’s current fiscal year. The highest revenue estimate was $6.42B, while the lowest revenue estimate was $6.32B, resulting in an average revenue estimate of $6.36B. In the same quarter a year ago, actual revenue was $5.97BBased on 12 analysts’ estimates, the company’s revenue will be $6.64B in the next fiscal year. The high estimate is $6.9B and the low estimate is $6.47B.
